| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.093 | 0.03 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.086 | 0.07 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.072 | 0.09 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.064 | 0.2 |